Senior insider sale
See Remarks at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.69M
45.01K shares
What this filing means
STRUTHERS RICHARD SCOTT plans to sell 45.01K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $1.69M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001628280-26-017946
DirectorOfficer· See Remarks
Since Jul 2018
45.01K
Shares to sell
$1.69M
Approx. market value
45.01K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
3/15/2026
45.01KTotal acquired45.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2026 | Restricted Stock Unit Vesting Compensation | 45.01K | — |
| Total | 45.01K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
45.01K
Market value
$1.69M
3/16/2026
Total
Units
45.01K
Value
$1.69M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/16/2026 | 45.01K | $1.69M | Nasdaq | Planned |
| Total | 45.01K | $1.69M | ||